glycosylated serum protein

used to measure control of glycemia
Also Known As:
glycosylated blood proteins; serum protein, glycosylated
Networked: 21 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results


1. Ren, Chunjiu: 1 article (12/2014)
2. Mu, Zhimei: 1 article (12/2014)
3. Zhang, Yao: 1 article (12/2014)
4. Wang, Yanwen: 1 article (12/2014)
5. Gao, Huiju: 1 article (12/2014)
6. Cui, Weizheng: 1 article (12/2014)
7. Lu, Guobing: 1 article (12/2014)
8. Ouyang, Bin: 1 article (06/2014)
9. Chen, Sheng-Fu: 1 article (06/2014)
10. Yao, Feng-Juan: 1 article (06/2014)

Related Diseases

1. Gestational Diabetes (Gestational Diabetes Mellitus)
2. Diabetes Mellitus
3. Body Weight (Weight, Body)
09/01/2013 - "The gestational and lactational exposure to PFOS led to low body weight from birth to weaning, and evoked signs of a prediabetic state, with elevated fasting serum insulin and leptin level, impaired glucose tolerance, though the fasting serum glucose and glycosylated serum protein level were normal. "
03/01/2012 - "The decrease in body weight, serum insulin level, and the increase in blood glucose level, glycosylated serum protein (GSP), total cholesterol (TC) and triglycerides (TG) in liver were observed in diabetic mice. "
05/01/2013 - "Oral administration of PC (100 mg/kg, once per day for 3 weeks) on KKAy mice were investigated by monitoring the changes in body weight, food intake, fasting plasma glucose level, 24 h random blood glucose levels, oral glucose tolerance tests (OGTTs), glycosylated serum protein (GSP), fasting serum insulin (FINS), glycogen, triglyceride (TG), total cholesterol (TC), total antioxidative capability (T-AOC) and malondialdehyde (MDA). "
12/01/2014 - "Oral administration of MLP at 50-200mg/kgbodyweight daily for 5weeks significantly reduced the levels of fasting blood glucose (FBG), glycosylated serum protein (GSP), serum total cholesterol (TC), and serum triglyceride (TG), and increased the body weight, fasting insulin (FINS), C-peptide (C-P), liver glycogen, liver glucokinase, and serum high-density lipoprotein cholesterol (HDL-C). "
04/01/2007 - "The effects of MT-alpha-glucan (450 or 150 mg kg (-1)) on diabetic mice were investigated by observing the changes in body weight, the level of fasting plasma glucose, glycosylated serum protein (GSP), hepatic glycogen, serum insulin, triglycerides, cholesterol, free fatty acid, liver superoxide dismutase (SOD), glutathione peroxidase (GSHpx), reduced glutathione (GSH) and malondialdehyde (MDA). "
4. Type 2 Diabetes Mellitus (MODY)
5. Prediabetic State (Prediabetes)

Related Drugs and Biologics

1. Glycosylated Hemoglobin A (Glycosylated Hemoglobin)
2. Glucose (Dextrose)
3. Insulin (Novolin)
4. Blood Glucose (Blood Sugar)
5. Cholesterol
6. Fructosamine
7. Triglycerides (Triacylglycerol)
8. Malondialdehyde (Propanedial)
9. Liver Glycogen
10. Leptin

Related Therapies and Procedures

1. Oral Administration